Glaxosmithkline | GSK - EPS Earnings Per Share



Glaxosmithkline reported $0.35 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
1.24 0.47 Oct/29 2025
0.47 1.17 Jul/30 2025


Eps Change Date
AbbVie USD 2.97 0.51 Jun/2025
Amgen USD 6.02 1.12 Jun/2025
AstraZeneca USD 2.17 0.32 Jun/2025
Aurora Cannabis CAD -0.26 0.84 Jun/2025
Bausch Health Companies USD 1.05 0.37 Jun/2025
Bristol-Myers Squibb USD 1.46 0.34 Jun/2025
Canopy Growth CAD -0.22 0.89 Jun/2025
Corcept Therapeutics USD 0.29 0.12 Jun/2025
Drreddys Laboratories INR 17.02 0.08 Jun/2025
Eli Lilly USD 6.31 2.97 Jun/2025
GlaxoSmithKline GBP 0.47 0.02 Jun/2025
Glaxosmithkline USD 0.35 0.24 Jun/2025
J&J USD 2.77 0 Jun/2025
Merck USD 2.13 0.09 Jun/2025
Novartis USD 2.42 0.14 Jun/2025
Pacira USD 0.74 0.12 Jun/2025
Perrigo USD 0.57 0.03 Jun/2025
Pfizer USD 0.78 0.14 Jun/2025
Prestige Brands USD 0.95 0.05 Jun/2025
Roche Holding CHF 8.57 1.66 Dec/2024
Sanofi EUR 1.59 0.21 Jun/2025
Supernus Pharmaceuticals USD 0.4 0.61 Jun/2025
Takeda JPY 79.4 145.4 Jun/2025
Teva Pharmaceutical Industries USD 2.22 0.34 Jun/2025
Zoetis USD 1.76 0.28 Jun/2025